A survey examining the impact of COVID-19 on food protein–induced enterocolitis syndrome

Brit Trogen; Hope Jin; Antonella Cianferoni; Mirna Chehade; Fallon Schultz; Amity Chavez; Christopher Warren; Anna H. Nowak-Wegrzyn

doi:10.1016/j.jaip.2021.10.053

A survey examining the impact of COVID-19 on food protein–induced enterocolitis syndrome

Brit Trogen, Hope Jin, Antonella Cianferoni, Mirna Chehade, Fallon Schultz, Amity Chavez, Christopher Warren, Anna H. Nowak-Wegrzyn

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	312-314.e3
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	10
Issue number	1
DOIs	https://doi.org/10.1016/j.jaip.2021.10.053
State	Published - Jan 2022

Access to Document

10.1016/j.jaip.2021.10.053

Cite this

@article{2b02985262d749a7b28105079b16f0f2,

title = "A survey examining the impact of COVID-19 on food protein–induced enterocolitis syndrome",

author = "Brit Trogen and Hope Jin and Antonella Cianferoni and Mirna Chehade and Fallon Schultz and Amity Chavez and Christopher Warren and Nowak-Wegrzyn, {Anna H.}",

note = "Funding Information: Conflicts of interest: M. Chehade received research funding from the NIH (R01-AI140133, R01-ES031940, U54-AI117804), APFED/AAAAI, and Danone; clinical trial funding from Regeneron, Allakos, Shire/Takeda, AstraZeneca, and Adare/Ellodi; consulting fees from Regeneron, Allakos, Adare, Shire/Takeda, AstraZeneca, Sanofi, and Bristol Myers Squibb; and serves on the Medical Advisory Board for the International FPIES Association (uncompensated). F. Schultz is the President and founder of the International FPIES Association. A. Chavez is the Vice President and Communications Director of the International FPIES Association. C. Warren received research funding from the NIH and Food Allergy Research and Education . A. H. Nowak-Wegrzyn reports royalty payments from UpToDate; personal fees from the American College of Allergy, Asthma, and Immunology as Deputy Editor of the Annals of Allergy, Asthma, and Immunology; consulting fees from Nestle, Nutricia, Novartis, and Aimmune outside of the submitted work; serves as the Chair of the Medical advisory Board for the International FPIES Association (uncompensated). The rest of the authors declare that they have no relevant conflicts of interest. ",

year = "2022",

month = jan,

doi = "10.1016/j.jaip.2021.10.053",

language = "English",

volume = "10",

pages = "312--314.e3",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - A survey examining the impact of COVID-19 on food protein–induced enterocolitis syndrome

AU - Trogen, Brit

AU - Jin, Hope

AU - Cianferoni, Antonella

AU - Chehade, Mirna

AU - Schultz, Fallon

AU - Chavez, Amity

AU - Warren, Christopher

AU - Nowak-Wegrzyn, Anna H.

N1 - Funding Information: Conflicts of interest: M. Chehade received research funding from the NIH (R01-AI140133, R01-ES031940, U54-AI117804), APFED/AAAAI, and Danone; clinical trial funding from Regeneron, Allakos, Shire/Takeda, AstraZeneca, and Adare/Ellodi; consulting fees from Regeneron, Allakos, Adare, Shire/Takeda, AstraZeneca, Sanofi, and Bristol Myers Squibb; and serves on the Medical Advisory Board for the International FPIES Association (uncompensated). F. Schultz is the President and founder of the International FPIES Association. A. Chavez is the Vice President and Communications Director of the International FPIES Association. C. Warren received research funding from the NIH and Food Allergy Research and Education . A. H. Nowak-Wegrzyn reports royalty payments from UpToDate; personal fees from the American College of Allergy, Asthma, and Immunology as Deputy Editor of the Annals of Allergy, Asthma, and Immunology; consulting fees from Nestle, Nutricia, Novartis, and Aimmune outside of the submitted work; serves as the Chair of the Medical advisory Board for the International FPIES Association (uncompensated). The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85120168676&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2021.10.053

DO - 10.1016/j.jaip.2021.10.053

M3 - Article

C2 - 34740821

AN - SCOPUS:85120168676

SN - 2213-2198

VL - 10

SP - 312-314.e3

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 1

ER -